91 related articles for article (PubMed ID: 11092291)
1. Age-related macular degeneration in newly diagnosed type 2 diabetic patients and control subjects: a 10-year follow-up on evolution, risk factors, and prognostic significance.
Voutilainen-Kaunisto RM; Teräsvirta ME; Uusitupa MI; Niskanen LK
Diabetes Care; 2000 Nov; 23(11):1672-8. PubMed ID: 11092291
[TBL] [Abstract][Full Text] [Related]
2. Occurrence and predictors of retinopathy and visual acuity in Type 2 diabetic patients and control subjects. 10-year follow-up from the diagnosis.
Voutilainen-Kaunisto RM; Teräsvirta ME; Uusitupa MI; Niskanen LK
J Diabetes Complications; 2001; 15(1):24-33. PubMed ID: 11259923
[TBL] [Abstract][Full Text] [Related]
3. Maculopathy and visual acuity in newly diagnosed type 2 diabetic patients and non-diabetic subjects: a 10-year follow-up study.
Voutilainen-Kaunisto R; Teräsvirta M; Uusitupa M; Niskanen L
Acta Ophthalmol Scand; 2001 Apr; 79(2):163-8. PubMed ID: 11284755
[TBL] [Abstract][Full Text] [Related]
4. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects.
Uusitupa MI; Niskanen LK; Siitonen O; Voutilainen E; Pyörälä K
Diabetologia; 1993 Nov; 36(11):1175-84. PubMed ID: 8270133
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
Tan JS; Mitchell P; Smith W; Wang JJ
Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090
[TBL] [Abstract][Full Text] [Related]
6. [Results of the use of antioxidant and angioprotective agents in type 2 diabetes patients with diabetic retinopathy and age-related macular degeneration].
Moshetova LK; Vorob'eva IV; Alekseev IB; Mikhaleva LG
Vestn Oftalmol; 2015; 131(3):34-44. PubMed ID: 26310005
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis.
Niskanen L; Turpeinen A; Penttilä I; Uusitupa MI
Diabetes Care; 1998 Nov; 21(11):1861-9. PubMed ID: 9802734
[TBL] [Abstract][Full Text] [Related]
8. High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy.
Rajala U; Pajunpää H; Koskela P; Keinänen-Kiukaanniemi S
Diabetes Care; 2000 Jul; 23(7):957-61. PubMed ID: 10895846
[TBL] [Abstract][Full Text] [Related]
9. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.
Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
Diabetes Care; 2007 Feb; 30(2):292-9. PubMed ID: 17259497
[TBL] [Abstract][Full Text] [Related]
10. Visual Function in Older Eyes in Normal Macular Health: Association with Incident Early Age-Related Macular Degeneration 3 Years Later.
Owsley C; Clark ME; Huisingh CE; Curcio CA; McGwin G
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1782-9. PubMed ID: 27074381
[TBL] [Abstract][Full Text] [Related]
11. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.
Seddon JM; George S; Rosner B; Rifai N
Arch Ophthalmol; 2005 Jun; 123(6):774-82. PubMed ID: 15955978
[TBL] [Abstract][Full Text] [Related]
12. Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death.
Yashkin AP; Hahn P; Sloan FA
Ophthalmology; 2016 Oct; 123(10):2225-31. PubMed ID: 27523614
[TBL] [Abstract][Full Text] [Related]
13. Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up.
Wu J; Cho E; Willett WC; Sastry SM; Schaumberg DA
JAMA Ophthalmol; 2015 Dec; 133(12):1415-24. PubMed ID: 26447482
[TBL] [Abstract][Full Text] [Related]
14. Association of Metformin Use With Age-Related Macular Degeneration: A Case-Control Study.
Blitzer AL; Ham SA; Colby KA; Skondra D
JAMA Ophthalmol; 2021 Mar; 139(3):302-309. PubMed ID: 33475696
[TBL] [Abstract][Full Text] [Related]
15. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study.
van Leeuwen R; Klaver CC; Vingerling JR; Hofman A; de Jong PT
Arch Ophthalmol; 2003 Apr; 121(4):519-26. PubMed ID: 12695249
[TBL] [Abstract][Full Text] [Related]
16. Age-related macular degeneration in a South Indian population, with and without diabetes.
Srinivasan S; Swaminathan G; Kulothungan V; Ganesan S; Sharma T; Raman R
Eye (Lond); 2017 Aug; 31(8):1176-1183. PubMed ID: 28387762
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk factors associated with age-related macular degeneration: the Tromsø Study.
Erke MG; Bertelsen G; Peto T; Sjølie AK; Lindekleiv H; Njølstad I
Acta Ophthalmol; 2014 Nov; 92(7):662-9. PubMed ID: 24460653
[TBL] [Abstract][Full Text] [Related]
18. Ethnic Differences in the Association Between Age-Related Macular Degeneration and Vision-Specific Functioning.
Fenwick EK; Man REK; Cheung CMG; Sabanayagam C; Cheng CY; Neelam K; Chua J; Gan ATL; Mitchell P; Wong TY; Lamoureux EL
JAMA Ophthalmol; 2017 May; 135(5):469-476. PubMed ID: 28358956
[TBL] [Abstract][Full Text] [Related]
19. Age-Related Macular Degeneration With Visual Disability Is Associated With Cardiovascular Disease Risk in the Korean Nationwide Cohort.
Jung W; Han K; Kim B; Hwang S; Yoon JM; Park J; Lim DH; Shin DW
J Am Heart Assoc; 2023 May; 12(9):e028027. PubMed ID: 37119082
[TBL] [Abstract][Full Text] [Related]
20. Diabetes, cardiovascular morbidity, and risk of age-related macular degeneration in a primary care population.
Vassilev ZP; Ruigómez A; Soriano-Gabarró M; García Rodríguez LA
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1585-92. PubMed ID: 25670489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
